Phibro Animal Health Corporation
PAHC
$38.25
-$0.33-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 396.75M | 383.54M | 373.91M | 363.89M | 378.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 396.75M | 383.54M | 373.91M | 363.89M | 378.70M |
| Cost of Revenue | 270.85M | 257.87M | 240.42M | 242.99M | 266.35M |
| Gross Profit | 125.90M | 125.68M | 133.50M | 120.90M | 112.35M |
| SG&A Expenses | 81.27M | 77.50M | 78.50M | 72.05M | 71.07M |
| Depreciation & Amortization | 2.40M | -- | -- | -- | 2.38M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 354.52M | 335.37M | 318.92M | 315.04M | 339.79M |
| Operating Income | 42.22M | 48.17M | 54.99M | 48.85M | 38.91M |
| Income Before Tax | 32.34M | 32.31M | 36.43M | 36.27M | 23.85M |
| Income Tax Expenses | 10.63M | 8.29M | 8.97M | 9.74M | 6.62M |
| Earnings from Continuing Operations | 21.71M | 24.02M | 27.46M | 26.53M | 17.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.71M | 24.02M | 27.46M | 26.53M | 17.22M |
| EBIT | 42.22M | 48.17M | 54.99M | 48.85M | 38.91M |
| EBITDA | 54.05M | 60.62M | 67.88M | 61.68M | 49.90M |
| EPS Basic | 0.53 | 0.59 | 0.68 | 0.65 | 0.43 |
| Normalized Basic EPS | 0.41 | 0.55 | 0.63 | 0.52 | 0.45 |
| EPS Diluted | 0.53 | 0.59 | 0.67 | 0.65 | 0.43 |
| Normalized Diluted EPS | 0.40 | 0.55 | 0.63 | 0.52 | 0.45 |
| Average Basic Shares Outstanding | 40.60M | 40.55M | 40.53M | 40.53M | 40.50M |
| Average Diluted Shares Outstanding | 41.00M | 41.04M | 40.96M | 40.88M | 40.70M |
| Dividend Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Payout Ratio | 22.42% | 20.26% | 17.71% | 18.34% | 28.24% |